Prostate-specific transcription factor hPSE is translated only in normal prostate epithelial cells

Cancer Research

Volumn 60, Issue 5, 2000, Pages 1348-1352

  Nozawa, Masahiro ^a,b   Yomogida, Kentaro ^a   Kanno, Nobufumi ^b   Nonomura, Norio ^b   Miki, Tsuneharu ^b   Okuyama, Akihiko ^b   Nishimune, Yoshitake ^a   Nozaki, Masami ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DELETION MUTANT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; TRANSLATION REGULATION;

CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; HUMANS; MALE; MUTATION; PROSTATE; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0034162031     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Scher, H. I., and Kelly, W. K. Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer. J. Clin. Oncol., 11: 1566-1572, 1993.
2. Mostofi, F. K., Davis, C. J., Jr., and Sesterhenn, I. A. Pathology of carcinoma of the prostate. Cancer (Phila.), 70: 235-253, 1992.
3. Mohler, J. L., Partin, A. W., Epstein, J. I., Becker, R. L., Mikel, U. V., Sesterhenn, I. A., Mostofi, F. K., Gleason, D. F., Sharief, Y., and Coffey, D. S. Prediction of prognosis in untreated stage A2 prostatic carcinoma. Cancer (Phila.), 69: 511-519, 1992.
4. Cleary, M. L. Oncogenic conversion of transcription factors by chromosomal translocations. Cell. 66: 619-622, 1991.
5. Bassuk, A. G., and Leiden, J. M. The role of Ets transcription factors in the development and function of the mammalian immune system. Adv. Immunol., 64: 65-104, 1997.
6. Papas, T. S., Bhat, N. K., Spyropoulos, D. D., Mjaatvedt, A. E., Vournakis, J., Seth, A., and Watson, D. K. Functional relationships among ETS gene family members. Leukemia, 11: 557-566, 1997.
7. Watson, D. K., Ascione, R., and Papas, T. S. Molecular analysis of the ets genes and their products. Crit. Rev. Oncog., 1: 409-436, 1990.
8. Hirota, S., Ito, A., Morii, E., Wanaka, A., Tohyama, M., Kitamura, Y., and Nomura, S. Localization of mRNA for c-kil receptor and its ligand in the brain of adult rats: an analysis using in situ hybridization histochemistry. Brain Res. Mol. Brain Res., 15: 47-54, 1992.
9. Schaeren-Wiemers, N., and Gerfin-Moser, A. A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes. Histochemistry, 100: 431-440, 1993.
10. Tamir, A., Howard, J., Higgins, R. R., Li, Y. J., Berger, L., Zacksenhaus, E., Reis, M., and Ben-David, Y. Fli-I, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol. Cell. Biol., 19: 4452-4464, 1999.
11. Orkin, S. H., Porcher, C., Fujiwara, Y., Visvader, J., and Wang, L. C. Intersections between blood cell development and leukemia genes. Cancer Res., 59 (Suppl.): 1784s-1788s, 1999.
12. Liu, A. Y., Corey, E., Vessella, R. L., Lange, P. H., True, L. D., Huang, G. M., Nelson, P. S., and Hood, L. Identification of differentially expressed prostate genes: increased expression of transcription factor ETS-2 in prostate cancer. Prostate, 30: 145-153, 1997.
13. Sementchenko, V. I., Schweinfest, C. W., Papas, T. S., and Watson, D. K. ETS2 function is required to maintain the transformed state of human prostate cancer cells. Oncogene, 17: 2883-2888, 1998.
14. Wasilenko, W. J., Palad, A. J., Somers, K. D., Blackmore, P. F., Kohn, E. C., Rhim, J. S., Wright, G. L., Jr., and Schellhammer, P. F. Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines. Int. J. Cancer, 68: 259-264, 1996.
15. Gambarotta, G., Boccaccio, C., Giordano, S., Ando, M., Stella, M. C., and Comoglio, P. M. Ets up-regulates MET transcription. Oncogene, 13: 1911-1917, 1996.
16. Pisters, L. L., Troncoso, P., Zhau, H. E., Li, W., von Eschenbach, A. C., and Chung, L. W. c-met proto-oncogene expression in benign and malignant human prostate tissues. J. Urol., 154: 293-298, 1995.
17. Galang, C. K., Garcia-Ramirez, J., Solski, P. A., Westwick, J. K., Der, C. J., Neznanov, N. N., Oshima, R. G., and Hauser, C. A. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-KB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J. Biol. Chem., 271: 7992-7998, 1996.
18. Langer, S. J., Bortner, D. M., Roussel, M. F., Sherr, C. J., and Ostrowski, M. C. Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression. Mol. Cell. Biol., 12: 5355-5362, 1992.
19. Zhau, H. E., Wan, D. S., Zhou, J., Miller, G. J., and von Eschenbach, A. C. Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines. Mol. Carcinog., 5: 320-327, 1992.
20. Zhau, H. Y., Zhou, J., Symmans, W. F., Chen, B. Q., Chang, S. M., Sikes, R. A., and Chung, L. W. Transfected neu oncogene induces human prostate cancer metastasis. Prostate, 28: 73-83, 1996.
21. Zhang, M., Magit, D., and Sager, R. Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor. Proc. Natl. Acad. Sci. USA, 94: 5673-5678, 1997.
22. Pain, V. M. Initiation of protein synthesis in eukaryotic cells. Eur. J. Biochem., 236: 747-771, 1996.
23. Stansfield, I., Jones, K. M., and Tuite, M. F. The end in sight: terminating translation in eukaryotes. Trends Biochem. Sci., 20: 489-491, 1995.
24. Day, D. A., and Tuite, M. F. Post-transcriptional gene regulatory mechanisms in eukaryotes: an overview. J. Endocrinol., 757, 361-371, 1998.
25. Goossen, B., Caughman, S. W., Harford, J. B., Klausner, R. D., and Hentze, M. W. Translational repression by a complex between the iron-responsive element of ferritin mRNA and its specific cytoplasmic binding protein is position-dependent in vivo. EMBO J., 9: 4127-4133, 1990.
26. Gallic, D. R., and Walbot, V. RNA pseudoknot domain of tobacco mosaic virus can functionally substitute for a poly(A) tail in plant and animal cells. Genes Dev., 4: 1149-1157, 1990.
27. Leathers, V., Tanguay, R., Kobayashi, M., and Gallie, D. R. A phylogenetically conserved sequence within viral 3′ untranslated RNA pseudoknots regulates translation. Mol. Cell. Biol., 13: 5331-5347, 1993.
28. Ostareck-Lederer, A., Ostareck, D. H., Standart, N., and Thiele, B. J. Translation of 15-lipoxygenase mRNA is inhibited by a protein that binds to a repeated sequence in the 3′ untranslated region. EMBO J., 13: 1476-1481, 1994.
29. Kruys, V., Marinx, O., Shaw, G., Deschamps, J., and Huez, G. Translational blockade imposed by cytokine-derived UA-rich sequences. Science (Washington DC), 245: 852-855, 1989.
30. Low, S. C., and Berry, M. J. Knowing when not to stop: selenocysteine incorporation in eukaryotes. Trends Biochem. Sci., 21: 203-208, 1996.
31. Gallie, D. R., Lewis, N. J., and Marzluff, W. F. The histone 3′-terminal stem-loop is necessary for translation in Chinese hamster ovary cells. Nucleic Acids Res., 24: 1954-1962, 1996.
32. Kozak, M. Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs. Mol. Cell. Biol., 9: 5134-5142, 1989.